In Tennessee, a woman survived two administered doses of a lethal drug, leaving the state's execution protocol under investigation and the machinery of capital punishment itself in question. The same drug, the same dosage, and the same essential method are scheduled for use in Texas within days. What this moment reveals is not merely a procedural failure, but the deeper tension between a society's claim to controlled, humane finality and the irreducible uncertainty of the human body. When the state cannot explain why death did not come, the silence around that failure becomes its own kind of r
Tennessee execution failure prompts scrutiny of Texas lethal injection protocol
We just don't know what people are doing. We can't verify anything.
So Tennessee's execution failed, and now Texas is about to carry out another one using the same method. Are we sure Texas would have the same problem?
That's the thing—we don't know. Both states use identical pentobarbital doses and basically the same protocol. But what went wrong in Tennessee hasn't been determined yet. It could be the drug itself, how it was injected, where the IV was placed, the execution team's training, or the inmate's medical condition.
Right, and that's the key point. We have no idea which of those factors caused Pike to survive. So saying "Texas uses the same protocol" doesn't actually tell us whether Texas would face the same failure.
Exactly. And that's where the secrecy becomes a real problem. Experts say we can't independently verify what states are doing or what goes wrong because execution procedures are kept closed off from outside scrutiny.
So if Texas had a similar failure, would we even know what caused it?
Probably not immediately. And that's what the experts are frustrated about—states could learn from Tennessee's failure, but only if the investigation is transparent and thorough.
Tennessee has paused executions to investigate. Texas hasn't announced any pause or any review of its procedures in response to what happened.
Is there any indication Texas is looking into this at all?
Not from what the reporting shows. The Department of Criminal Justice said it's "ready" to proceed on October 7. No mention of internal review, no indication of changes planned.
Which is why experts like Corinna Lain are saying states should be asking themselves hard questions right now—what can go wrong, and what can we actually do about it?
But if the answers to those questions stay secret, does it matter?
That's the uncomfortable question the reporting leaves us with.
El Pulso
- A woman sentenced to death survived two full doses of pentobarbital in Tennessee, and no one yet knows why — leaving the state's execution protocol under active investigation.
- Texas, using an identical single-drug protocol and the same 5-gram dosage, has an execution scheduled for October 7 and has announced no pause or procedural review in response.
- Experts warn that IV placement, drug quality, team training, and the prisoner's own medical condition are all variables that can silently undermine a lethal injection — and any one of them may have failed in Tennessee.
- The secrecy surrounding execution procedures means outside experts and the public cannot independently verify what went wrong, leaving the same unexamined risks in place for the next scheduled death.
- Tennessee has paused executions pending investigation; Texas has not, and its Department of Criminal Justice describes its process as structured and legally regulated — and says it is ready to proceed.
In Tennessee, a woman survived two administered doses of a lethal drug, leaving the state's execution protocol under investigation and the machinery of capital punishment itself in question. The same drug, the same dosage, and the same essential method are scheduled for use in Texas within days. What this moment reveals is not merely a procedural failure, but the deeper tension between a society's claim to controlled, humane finality and the irreducible uncertainty of the human body. When the state cannot explain why death did not come, the silence around that failure becomes its own kind of reckoning.
On Wednesday, Christa Pike survived an execution attempt in Tennessee after receiving two doses of pentobarbital. State officials said their staff followed established protocol. The procedure did not kill her.
Both Tennessee and Texas use a single-drug pentobarbital protocol with an initial 5-gram dose and a second if the person remains alive. Law professor Corinna Barrett Lain, who has written extensively on lethal injection, described the two states' protocols as essentially identical. Texas has carried out 602 executions under this system and has an execution scheduled for October 7. Its Department of Criminal Justice says it remains prepared to proceed.
What caused Pike's survival is still unknown. Fordham law professor Deborah Denno identified several possible factors: the condition of the drugs, the training of the execution team, the prisoner's medical condition, and — critically — the placement of the IV lines. A poorly positioned line can prevent an inmate from receiving a sufficient dose. Whether the failure involved the drug itself, its administration, or some other variable has not yet been determined.
The case has also exposed a structural problem: secrecy. Denno noted that the opacity surrounding lethal injection procedures makes independent assessment nearly impossible. 'We just don't know what people are doing,' she said. 'We can't verify anything.' Lain argued that other states using similar protocols should conduct their own reviews before proceeding with further executions.
Tennessee has paused executions while investigating. Texas has not. Its agency characterized its process as a 'structured, legally regulated death penalty procedure' and has signaled no change to its October 7 schedule. Whether the Tennessee investigation will eventually yield findings with implications for other states depends, experts say, on whether those findings are ever made public.
On Wednesday, Christa Pike survived an execution attempt in Tennessee after officials administered two doses of pentobarbital. The state said its staff followed established protocol. The procedure did not kill her. Now, with Texas scheduled to carry out an execution on October 7 using the same drug and the same basic method, questions are mounting about what can go wrong when a state tries to end a life through lethal injection.
Both Tennessee and Texas employ a single-drug protocol centered on pentobarbital. Each state calls for an initial 5-gram dose, followed by another if the person remains alive. According to Corinna Barrett Lain, a law professor at the University of Richmond and author of a book on lethal injection procedures, the two states use identical drugs, identical amounts, and essentially identical protocols. Texas has carried out 602 executions under this system. The state's Department of Criminal Justice said it remains prepared to proceed with the scheduled execution, noting that its procedure uses a medically trained drug team administering pentobarbital through two intravenous lines.
What caused Pike's survival remains unknown. Investigators have not yet determined why the execution failed. Experts point to several possible culprits. Deborah Denno, a law professor at Fordham University, identified the condition of the drugs themselves, the training and experience of the execution team, the prisoner's medical condition, and the placement of the IV lines as critical variables. IV placement, she emphasized, is particularly consequential. A poorly positioned line means the inmate will not receive a sufficient dose of the drug. Beyond that, questions linger about whether there was a problem with the pentobarbital itself, how it was administered, whether the execution team followed its procedures correctly, or whether Pike's medical condition played a role.
The Tennessee case has exposed a deeper problem: secrecy. Denno said the opacity surrounding lethal injection procedures makes it nearly impossible for the public or outside experts to independently assess what happened when an execution fails. "We just don't know what people are doing," she said. "We can't verify anything." Lain argued that the Tennessee failure should prompt other states using similar protocols to conduct their own reviews before another execution takes place. She suggested officials ask themselves what can go wrong and what they can actually do something about.
Tennessee has paused executions while investigating Pike's case and considering whether procedural changes are necessary. Texas has announced no such pause. The Department of Criminal Justice has not indicated that the Tennessee case will alter Texas' current lethal injection procedures, nor has it announced any change to the October 7 execution schedule. The agency characterized its process as a "structured, legally regulated death penalty procedure" and said it stands ready to proceed.
Experts say the Tennessee investigation could eventually reveal whether the failure involved the drug, its administration, IV access, or some other factor—and whether those findings carry implications for other states relying on similar protocols. But that information will only matter if it becomes public. For now, the machinery of execution in Texas continues on its scheduled course, even as questions about the reliability of the method remain unanswered.
Citas Notables
If you don't place the IV correctly, then the inmate's not going to get a sufficient injection of drugs.— Deborah Denno, Fordham University School of Law
I'd be asking myself, what are the things that can go wrong, and what are the things I can do something about?— Corinna Barrett Lain, University of Richmond School of Law